Body-Surface-Area Dosing Versus Weight-Based Dosing

Why Compare Two Size-Based Dose Rules?

A dose expressed in mg/kg and a dose expressed in mg/m² both adjust an amount of drug for a child's size, but they do not make the same adjustment. Weight-based dosing scales the dose directly with weight. Body-surface-area (BSA) dosing scales it with an estimate that depends on both height and weight. As a result, the two rules can recommend different amounts for children of different sizes—even when calibrated to agree for one reference child.

That difference is a mathematical consequence of the scaling rules, not evidence by itself that one rule predicts exposure or clinical response better. For a particular drug, the relevant question is whether the recommended dose, given under the intended conditions, achieves an appropriate exposure and remains safe. A size formula is a dosing convention; it is not, on its own, a pharmacokinetic model.

Definition: A weight-based dose rule has the form \(D_W=d_W W\), where \(D_W\) is the dose amount, \(d_W\) is a prescribed dose per unit of body weight, and \(W\) is weight. A BSA-based dose rule has the form \(D_A=d_A A\), where \(A\) is body-surface area and \(d_A\) is a prescribed dose per unit of area. For these rules to be directly comparable, their units, dose occasion, route, and any relevant schedule must be aligned.

Calculating BSA and Interpreting the Scaling

A commonly used calculation is the Mosteller equation. With height \(H\) in centimetres and weight \(W\) in kilograms, it estimates area in square metres:

A=\sqrt{\frac{H W}{3600}}\ \text{m}^2

The units in this formula are part of the convention: enter height in centimetres and weight in kilograms. Do not substitute height in metres without changing the formula. A BSA recommendation is then calculated by multiplying \(A\) by a dose rate in mg/m²; a weight-based recommendation is calculated by multiplying \(W\) by a rate in mg/kg. The resulting dose amounts are in mg.

For a fixed height, the Mosteller estimate is proportional to the square root of weight, not weight itself. For a fixed weight, it is proportional to the square root of height. Thus, BSA dosing responds to both measurements, while weight-based dosing responds only to weight. This distinction does not establish which rule is more biologically appropriate for a drug.

Assumptions to check: A dose-rate calculation assumes that the stated rate applies to the patient and dosing context, that height and weight are measured and entered in the specified units, and that the prescribed dose amount is intended to scale according to the stated rule. Interpreting either rule as a way to preserve exposure requires additional support: for example, that the drug's disposition and dose–exposure relationship make that scaling suitable over the relevant range. A dose formula alone does not establish those pharmacokinetic conditions.

Calibrating the Rules to a Reference Child

A fair comparison can begin by choosing dose rates that produce the same dose for a stated reference child. This isolates how the rules diverge away from that child. It does not show that the shared reference dose is correct, nor does it validate either scaling rule.

Suppose the two rules agree at reference weight \(W_0\) and reference BSA \(A_0\). Then \(d_W W_0=d_A A_0\), so \(d_A=d_W W_0/A_0\). At another size, their ratio is:

\frac{D_A}{D_W} = \frac{d_A A}{d_W W} = \frac{A/W}{A_0/W_0}

This result follows by substituting the reference calibration \(d_A=d_W W_0/A_0\) into \(D_A/D_W=d_AA/(d_WW)\) and cancelling \(d_W\). The comparison therefore depends on how the ratio of BSA to weight changes between the patient and reference child. If \(A/W\) is higher than \(A_0/W_0\), the calibrated BSA rule gives the larger dose; if it is lower, the calibrated weight rule gives the larger dose.

Worked Example: Comparing Calibrated Recommendations

Hypothetical illustration, not a dosing recommendation. A weight-based rule is 4 mg/kg. A reference child is 110 cm tall and weighs 20 kg, so this rule gives 80 mg. Calibrate a BSA rule to give the same 80 mg for that child, then compare the rules for a child who is 75 cm and 10 kg and a child who is 145 cm and 40 kg.

For the reference child:

A_0=\sqrt{\frac{(110)(20)}{3600}} =\sqrt{0.611111\ldots} =0.7817\ \text{m}^2

The calibrated BSA rate is \(80/0.7817359\ldots=102.3\) mg/m² (rounded). For the smaller child, \(A=\sqrt{(75)(10)/3600}=0.4564\) m². The weight-based amount is \((4\ \text{mg/kg})(10\ \text{kg})=40\) mg. Using the reference-calibration ratio avoids inconsistency from multiplying rounded intermediate values:

D_A=80\sqrt{\frac{(75)(10)}{(110)(20)}} =80\sqrt{\frac{15}{44}} \approx 46.71\ \text{mg}

For this child, the calibrated BSA rule gives about 6.71 mg more than the weight rule. For the larger child, \(A=\sqrt{(145)(40)/3600}=1.269\) m² and the weight rule gives \((4\ \text{mg/kg})(40\ \text{kg})=160\) mg. The calibrated BSA amount is:

D_A=80\sqrt{\frac{(145)(40)}{(110)(20)}} =80\sqrt{\frac{29}{11}} \approx 129.9\ \text{mg}

Here the BSA rule gives about 30.1 mg less than the weight rule. The difference changes direction across these examples because \(A/W\) is above the reference value for the smaller child and below it for the larger child. These arithmetic results demonstrate how the rules diverge; they do not establish which calculated dose would achieve the intended exposure.

How the Rules Respond to Changes in Size

The contrast is especially clear when height is held fixed. Under the Mosteller equation, doubling weight at fixed height multiplies BSA by \(\sqrt{2}\), while doubling weight-based dose multiplies its amount by 2. The following example compares the size-scaling pattern using separate illustrative dose rates. The rates are hypothetical and are not a recommendation for any drug.

Worked Example: Doubling Weight at Fixed Height

Hypothetical illustration. Consider two children both 100 cm tall, weighing 10 kg and 20 kg. Compare a BSA rule of 100 mg/m² with a weight rule of 4 mg/kg.

At 10 kg:

A_{10}=\sqrt{\frac{(100)(10)}{3600}}=0.5270\ \text{m}^2, \qquad D_A=(100\ \text{mg/m}^2)(0.5270\ \text{m}^2)=52.70\ \text{mg}

The weight-based amount is \((4\ \text{mg/kg})(10\ \text{kg})=40.00\) mg. At 20 kg:

A_{20}=\sqrt{\frac{(100)(20)}{3600}}=0.7454\ \text{m}^2, \qquad D_A=(100\ \text{mg/m}^2)(0.7454\ \text{m}^2)=74.54\ \text{mg}

The weight-based amount is \((4\ \text{mg/kg})(20\ \text{kg})=80.00\) mg. The BSA-based amount increases by a factor of \(74.54/52.70\approx1.414\), which is \(\sqrt{2}\) apart from rounding; the weight-based amount doubles. These are consequences of the formulas at fixed height. They should not be interpreted as a general comparison of expected exposure.

At the same weight, children of different heights receive the same amount under a weight-based rule but different amounts under a BSA rule. This can be shown without assuming a particular pharmacokinetic model:

Worked Example: Same Weight, Different Heights

Hypothetical illustration. Two children each weigh 20 kg, but one is 105 cm tall and the other is 120 cm tall. Compare a BSA rule of 100 mg/m² with a weight rule of 4 mg/kg.

For the 105 cm child, \(A=\sqrt{(105)(20)/3600}=0.7638\) m², giving \((100\ \text{mg/m}^2)(0.7638\ \text{m}^2)=76.38\) mg. For the 120 cm child, \(A=\sqrt{(120)(20)/3600}=0.8165\) m², giving \((100\ \text{mg/m}^2)(0.8165\ \text{m}^2)=81.65\) mg. The weight-based rule gives \((4\ \text{mg/kg})(20\ \text{kg})=80.00\) mg for each child. The difference between BSA recommendations is attributable to the height term in the BSA equation; it does not prove that height should or should not affect the drug dose.

What the Comparison Can—and Cannot—Tell You

Weight-based and BSA-based rules encode different relationships between dose and body size. In general, a dose rule \(D\propto W\) is linear in weight. Under the Mosteller equation, a rule \(D\propto A\) is proportional to \(\sqrt{H W}\). If height also changes systematically with weight, the relationship between BSA and weight is not the same as the fixed-height comparison above. The observed pattern depends on the children's actual height and weight.

Neither rule explicitly accounts for age-related maturation, organ function, disease, or other patient characteristics that may influence drug disposition. Earlier material on allometric and maturation scaling provides a pharmacokinetic framework for relating clearance to size and development; a simple BSA dose rule is not a substitute for that model. Conversely, a model-based dose calculation depends on the adequacy of its data, structure, and assumptions. The choice between approaches should be supported by drug-specific evidence and the intended clinical use.

When comparing published or prescribed recommendations, first align what is being compared: dose per administration versus total daily dose, route, interval, units, and any stated cap or eligibility condition. A difference in schedule cannot be explained by comparing dose amounts alone. Likewise, do not infer a dose rate by dividing an arbitrary dose by BSA or weight and then treat that rate as a validated rule.

Diagnostics, Failure Modes, and Alternatives

A practical check is to calculate the BSA, each dose amount, and the implied dose per kg for the same child. If two rules are calibrated to agree at one reference size, check whether their relative recommendations change smoothly and as expected as height and weight vary. Large or surprising differences should prompt verification of units, measurements, arithmetic, and the intended dosing convention before interpreting the result.

The main alternatives are not interchangeable formulas. A drug-specific fixed dose, an age-band rule, a weight-based rule, a BSA-based rule, and a model-based rule each embody different assumptions and may have different evidence behind them. Compare the applicable recommendation and its supporting evidence rather than choosing whichever calculation gives a preferred amount. Dose caps, where specified, alter the final recommendation and should be applied as stated; they do not change the underlying algebra of the uncapped rule.

Unit error: entering height in metres into the Mosteller formula while treating it as centimetres produces an invalid BSA. Check that height is in cm, weight in kg, and area in m².
False equivalence: matching both rules at one reference child does not make them equivalent elsewhere. Their scaling patterns differ.
Overinterpreting a calculation: a larger calculated dose does not imply greater or more appropriate exposure without information about drug disposition and dose–exposure behavior.
Inconsistent precision: multiplying rounded intermediate values can yield a slightly different result from using unrounded values. State rounding and carry adequate precision through the calculation.

A common mistake is to reason, “BSA includes height, so it must be more accurate for every child.” The correction is that including another measurement changes the rule, but accuracy requires evidence that the rule predicts the relevant pharmacokinetic or clinical target better in the population and context of use. BSA and weight-based calculations are not intrinsically ranked by their formulas alone.

Key takeaway: Weight-based dosing scales in direct proportion to weight; Mosteller BSA-based dosing scales with the square root of the product of height and weight. Calibrating both rules at one reference child makes their differences elsewhere visible, but does not establish which rule best achieves a drug-specific exposure or outcome.

Check Your Understanding

Use the stated formulas and show units. The questions use hypothetical values, not clinical recommendations.

A child is 90 cm tall and weighs 12 kg. Calculate BSA using the Mosteller equation.
For that child, calculate the dose from a hypothetical rule of 5 mg/kg and from a separate hypothetical rule of 80 mg/m².
At fixed height, weight increases fourfold. By what factor does a Mosteller BSA-based dose change, and by what factor does a weight-based dose change?
Two children have the same weight but different heights. Which rule gives them the same dose amount: mg/kg or mg/m²? Explain.
Why does agreement between the rules for one reference child not show that either rule is more appropriate for all children?

Solutions. (1) \(A=\sqrt{(90)(12)/3600}=\sqrt{0.3}=0.5477\) m². (2) The weight-based amount is \((5\ \text{mg/kg})(12\ \text{kg})=60.00\) mg. The BSA-based amount is \((80\ \text{mg/m}^2)(0.5477\ \text{m}^2)=43.82\) mg. These are two hypothetical calculations, not competing clinical advice. (3) With height fixed, BSA is proportional to \(\sqrt{W}\), so a fourfold increase in weight multiplies a BSA-based dose by \(\sqrt{4}=2\). A weight-based dose increases fourfold. (4) The mg/kg rule gives the same amount because both children have the same weight. The mg/m² rule can differ because BSA depends on height as well as weight. (5) Agreement at one reference child is a single calibration condition. Away from that reference, the rules have different scaling relationships, and choosing between them requires evidence about the drug, population, and intended target.